Memantine Merz

Memantine, the active ingredient in Memantine Merz, is an NMDA receptor antagonist presented as an oral tablet for oral use. It is indicated for the symptomatic treatment of moderate to severe Alzheimer’s disease in adult patients. The medication works by modulating glutamatergic neurotransmission, which may help preserve neuronal function.

GNH USA supplies Memantine Merz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing and regulatory support for global healthcare providers.

Memantine is used in the management of neurodegenerative disorders, specifically Alzheimer’s disease, by targeting excitatory neurotransmission. - Alzheimer’s disease: Improves cognition, functional abilities, and behavioral symptoms in patients with moderate to severe disease.

Adverse reactions to memantine may vary in frequency and severity.

Common Side Effects: - Dizziness: Transient sensation of light‑headedness or unsteadiness. - Headache: Mild to moderate head pain. - Constipation: Reduced bowel movements or hard stools. - Confusion: Temporary disorientation or difficulty concentrating. - Hypertension: Elevated blood pressure readings. - Somnolence: Increased sleepiness or fatigue.

Serious or Rare Side Effects: - Seizures: Uncontrolled convulsive episodes requiring medical attention. - Severe allergic reaction: Rash, itching, swelling, or difficulty breathing. - Hallucinations: Visual or auditory disturbances. - Cardiac arrhythmia: Irregular heart rhythm that may be symptomatic.

When prescribing memantine, clinicians should consider several precautionary measures to ensure patient safety. - Renal impairment: Adjust dose or monitor renal function in patients with reduced kidney clearance. - Hepatic impairment: Use with caution and monitor liver enzymes in patients with liver disease. - History of seizures: Evaluate risk and monitor for increased seizure activity. - Concurrent use with other NMDA antagonists: Avoid combined therapy to reduce additive CNS effects. - Pregnancy: Safety not established; weigh potential benefits against unknown risks. - Store at room temperature: Keep in the original packaging, protect from moisture and direct sunlight.

Memantine may interact with other medications, altering its efficacy or safety profile.

Major Interactions (Avoid): - Amantadine: Combined NMDA antagonism can increase neuropsychiatric side effects. - Ketamine: Additive CNS depression may occur. - Strong CYP450 inhibitors (e.g., quinidine): May raise memantine plasma concentrations.

Moderate Interactions (Monitor Closely): - Anticholinesterases (e.g., donepezil): Potential for additive cognitive effects; monitor response. - Diuretics (e.g., furosemide): May affect renal clearance of memantine. - NSAIDs: May increase risk of hypertension; observe blood pressure.